Deep-space biotech · Est. 2023

Biology engineered for the long voyage

Aphelion Bio builds living systems that survive what kills ordinary life — radiation, vacuum, deep time. Life support for the next era of exploration, and medicine for this one.

Lat 00.00 · Lon 00.00 · Aphelion — the farthest point, on purpose

The mission

Life should not stop at the edge of the atmosphere

Every organism on Earth was tuned by four billion years of a very specific address: one gravity, one magnetic field, one forgiving sky. Take that away and biology falls apart in hours.

We are re-tuning it for everywhere else. Our cells are designed for the places life was never meant to reach — and the science that gets them there turns out to heal people back home, too.

Radiation resistance becomes cancer therapy. Dormancy becomes organ preservation. The voyage funds the cure.

// mission log

Founded2023 · Q2
Team41 scientists
LabsNairobi · Reykjavík
Backing$120M · Series B
Patents28 filed

Platform

Numbers from the bench, not the brochure

0engineered strains in trial
0 kGyradiation survived intact
−80→120°Coperating range
0orbital payloads flown

Research pillars

Three problems between us and the stars

Solve any one and Earth medicine changes. Solve all three and the solar system opens.

RES-01

Radiation-hard cells

We rewrite DNA-repair pathways so our cell lines shrug off cosmic ray damage that would erase ordinary biology in days.

RES-02

Dormancy on demand

Engineered cryptobiosis lets tissues pause metabolism for years, then resume — for deep-space transit and for organ banking on Earth.

RES-03

Closed-loop life support

Photosynthetic consortia that turn CO₂, waste, and starlight into oxygen, protein, and pharmaceuticals inside a sealed hull.

Roadmap

The far point, one phase at a time

2024

First survivors

Our founding strain endured a full mission-equivalent radiation dose with functional repair. Proof the approach holds.

Shipped
2025

Orbit validation

Three payloads to low Earth orbit confirmed dormancy-and-revival cycles under real microgravity and flux.

Shipped
2026

Closed-loop pilot

A one-cubic-meter bioreactor sustaining oxygen balance for a two-person analog habitat, ninety days unbroken.

In progress
2028

Lunar surface trial

Deploying the full life-support consortium in a shielded lunar module — and licensing the Earth-side spin-outs.

Planned

Join us

Help write biology for the places we have not been

We are hiring synthetic biologists, cryobiologists, and systems engineers who read science fiction as a to-do list.

crew@aphelion.example
Designed by Gideon Awolesi